Florian Maria WurmFlorian Wurm received his academic training as a Biologist and Molecular Geneticist at the University of Giessen. He joined the Hoechst AG (Behringwerke) in Marburg as head of a laboratory in Virology. Working with immortalized mammalian cells for the establishment of production processes for alpha-interferons provided the first opportunity to combine basic research with medical application. In 1984 he joined Harvard Medical School in Boston as a Research Fellow in Molecular Biology. 1986 he took an offer from Genentech Inc. in San Francisco to work in Process Sciences on the development of large scale manufacturing processes for recombinant proteins. There he has held a number of leading positions and has acquired intimate knowledge in the generation of protein pharmaceuticals in mammalian cells in bioreactors (a number of which are now marketed products). In 1995 he joined the EPFL as a Professor for Biotechnology. Wurm has published more than 250 scientific papers and holds more than 20 patents/patent-applications. His H-index stands at 60 in 2021. He was Chairman (2005-2009) and is member of the Executive Board of the European Society of Animal Cell Technology (ESACT). He serves as a consultant to the pharmaceutical Biotech Industry, mainly in the fields of animal cell technology for recombinant protein production and in regulatory affairs. He works as a scientific reviewer and editior/asscciate editor for a number of international journals in the Biotech field. F.M. Wurm teaches classes to pre- and postgraduate students in the fields of Molecular and Cellular Biotechnology.
He was founder and Chief Scientific Officer of ExcellGene SA, a 2001 established company in Monthey, Switzerland. He took the position of President and CEO of ExcellGene in 2015. He retired from the CEO position in 2017 and continues to be President and Chief Scientific Officer of ExcellGene.
In 2008 Dr. Wurm was appointed Visiting Professor for Biotechnology at Jinan University in Guangzhou, China. He retired from his position at the EPFL in 2015. His laboratory is closed. With his team at ExcellGene and in collaboration with Dr. Paco Pino, Director of R&D, he continues to explore manufacturing sciences with animal cells in bioreactors.
Jean-Jacques MeisterCitoyen suisse, Jean-Jacques Meister est né en 1950. Il est titulaire d'un diplôme d'ingénieur en électronique et d'un diplôme d'ingénieur physicien, obtenu en 1979 à l'Ecole polytechnique fédérale de Lausanne (EPFL). Il poursuit sa formation à l'Institut des techniques biomédicales de l'Ecole Polytechnique Fédérale de Zurich et obtient son doctorat ès sciences en 1983. De 1984 à 1990, il travaille dans différents domaines de la physique biomédicale. Ses principales réalisations portent sur le développement de méthodes non-invasives utiles à la prévention et au diagnostic des maladies cardio-vasculaires: caractérisation des propriétés biomécaniques des artères, hémodynamique cardio-vasculaire, échographie Doppler ultrasonore. En 1990, il est nommé professeur de physique expérimentale à l'EPFL où il dirige le Laboratoire de génie médical jusqu'en 2001, puis le laboratoire de biophysique cellulaire. Ses activités de recherche concernent principalement la biophysique cellulaire: dynamique du cytosquelette, motilité & adhésion cellulaire et dynamique du calcium dans les muscles lisses. Lors d'un congé sabbatique en 2000, il complète sa formation en biologie moléculaire et cellulaire au célèbre Marine Biological Laboratory de Woods Hole, dans le Massachusetts, USA. Il enseigne la physique générale, la mécanique générale, le génie biomédical et la biophysique aux étudiants de diverses sections de l'EPFL. Il est auteur ou coauteur de plus de 230 publications scientifiques et chapitres de livres et titulaire de 8 brevets internationaux
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
Yves LeterrierYves Leterrier joined EPFL in 1993 and is a faculty member of the Materials Institute. He is a senior scientist and lecturer in the Laboratory for Processing of Advanced Composites (LPAC, previously Laboratory of Composite and Polymer Technology, LTC). Activities
2000-2005: Foundation and Chair of the Korea-Switzerland joint symposia on materials and micro-technologies2004-2008: Board member of FLEXIDIS (the European flexible display consortium) 2004-2009: Group leader on lightweight materials for Solar ImpulseSince 2008: Board member of the French Adhesion SocietySince 2000: President of the EPFL Materials Science Library commissionSince 2012: Editorial board member, Applied Surface ScienceSince 2014: Associate Editor, Frontiers in MaterialsSince 2021: Coordinator of the EPFL Minor on 'Engineering for Sustainability'
Background
1987: MS in materials science and solid state physics (INPL, France) 1991: PhD in materials science (Ecole des Mines, INPL, France) 1992: Research Associate, National Institute of Standards and Technology (NIST, USA)
Radivoje PopovicRadivoje Popovic received the Dipl. Ing. degree in engineering physics from the University of Belgrade, Yugoslavia in 1969, and the M.Sc and Dr.Sc. degrees in electronics from the University of Nis, Yugoslavia in 1974 and 1978.
From 1969 to 1981, he worked for Elektronska Industrija in Nis, Yugoslavia, where from 1978 to 1981 he was head of CMOS department. From 1982 to 1993, he was with Landis & Gyr AG, Central R&D in Zug, Switzerland, where from 1991 to 1993 he was vice president.
In 1994 Popovic joined EPFL (Swiss Federal Institute of Technology, Lausanne, Switzerland), as extraordinary professor for microtechnology systems, and became ordinary professor in 1997. He taught courses in conceptual product design, semiconductor device physics, microelectronics, optical detectors, and integrated sensors; and he was adviser of 20 PhD students. Since 2010 he is professor emeritus.
Currently, he is chief technology officer of SENIS AG (www.senis.ch).
Popovic has published a book on Hall effect devices, and is author or co-author of about 280 technical papers and 93 patent applications. He is co-founder of start-up companies Sentron AG, Sentronis AD, Senis AG, Ametes AG, and Sensima Technology SA. He is member of Swiss Academy of Engineering Sciences, Serbian Academy of Engineering Sciences, and senior member of IEEE.
Note: In publications, Radivoje Popovic is mostly cited as R.S. Popovic, Radivoje S. Popovic, or Rade Popovic; in patents, he is cited as Popovic Radivoje. 